The effects of PEGylation on LNP based mRNA delivery to the eye
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Gene therapy is now an effective approach to treat many forms of retinal degeneration. Delivery agents that are cell-specific, allow for multiple dosing regimens, and have low immunogenicity are needed to expand the utility of gene therapy for the retina. We generated eight novel lipid nanoparticles (LNPs) ranging in size from 50 nm to 150 nm by changing the PEG content from 5% to 0.5%, respectively. Subretinal injections of LNP-mRNA encoding luciferase revealed that 0.5% PEG content within nanoparticles elicits the highest expression. Similar injections of LNP delivered cre mRNA into Ai9 mice revealed cell-specific protein expression in the retinal pigment epithelium (RPE), confirmed by fundus photography and immunohistochemistry of whole globe cross-sections. To investigate mechanisms of LNP delivery to the eye, we injected mCherry mRNA using the subretinal approach in apoE-/- and Mertk-/- mice. RPE transfection was observed in both mouse models suggesting that LNP intracellular delivery is not solely dependent on apolipoprotein adsorption or phagocytosis. To investigate LNP penetration, particles were delivered to the vitreous chamber via an intravitreal injection. The 0.5% PEG particles mediated the highest luciferase activity and expression was observed in the Müller glia, the optic nerve head and the trabecular meshwork, but failed to reach the RPE. Overall, particles containing less PEG (~150 nm in size) mediated the highest expression in the eye. Thus far, these particles successfully transfect RPE, Müller cells, the optic nerve head and the trabecular meshwork based on route of administration which can expand the utility of LNP-mediated gene therapies for the eye.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, lipid-based transfection systems have shown success in their ability to transfer the target genes into retinal cells in several studies, and multiple lipid-based drugs for eye diseases are already available in the clinic35,79,87–91 and for the delivery of CRISPR or ribonucleoproteins for base editing.92,93”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [90]
Experimental — accuracy not yet measuredIn the citing paper
“The PEG-molecules at the surface prevent the individual LNPs from aggregating.”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Ryals et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., Ng, L. L., Palmiter, R. D., Hawrylycz, M. J., Jones, A. R., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2467 · Cited by 6,907
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859 · cited 2×
“In general, particles<500 nm are internalized via endocytosis, whereas particles >1000 nm utilize phagocytosis [22, 23].”
BackgroundResultEngineered nanoparticles interacting with cells: size matters
Shang, L., Nienhaus, K., & Nienhaus, G. U. (2014) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-12-5 · Cited by 1,316
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261 · cited 3×
“This was established by observing diminished LNP transfection efficiency in both apoE and LDLR mice [27].”
BackgroundLipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208
(1984) · PubMed · Cited by 1,200
Pharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Müller glial cell reprogramming and retina regeneration
Goldman, D. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3723 · Cited by 625
Patisiran: First Global Approval
Hoy, S. M. (2018) · Drugs · doi:10.1007/s40265-018-0983-6 · Cited by 614
Lipid nanoparticles enabling gene therapies: from concepts to clinical utility
Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592 · cited 1×
“Lipid based nanoparticles (LNP), being the most clinically advanced, are an attractive alternative gene delivery vehicle due to their modularity and safety profile [8, 9].”
Background
Research works printed but not linked: 1
- Kay C. Retinal Gene Therapies in Clinical Trials A proliferation of clinical trials means hope for patients. Retinal Physician. 2019 3; 16: 36– 40.
Cited by
Items 101–194 of 194
Lipid Nanocarrier‐Based mRNA Therapy: Challenges and Promise for Clinical Transformation
Li, W., Wang, C., Zhang, Y., & Lu, Y. (2024) · Small · doi:10.1002/smll.202310531 · Cited by 25
Vanluchene, H., Gillon, O., Peynshaert, K., Smedt, S. C. D., Sanders, N. N., Raemdonck, K., & Remaut, K. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114204 · Cited by 20
Tang, S., Huang, L., Ge, J., Li, J., Qiu, M., Zhang, Y., Long, M., Wu, G., Zhang, R., Ma, X., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03318-w · Cited by 19
Gu, J., Xu, Z., Liu, Q., Tang, S., Zhang, W., Xie, S., Chen, X., Chen, J., Yong, K., Yang, C., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302409 · Cited by 21
Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy
Gambaro, R. C., Berti, I. R., Limeres, M. J., Huck‐Iriart, C., Svensson, M., Ghazi, S. F.-E., Pretsch, L., Si, S., Lieberwirth, I., Gehring, S., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060771 · Cited by 20
Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review
Bai, Y., Cui, L., Liu, T., Wang, Z., Cao, H., He, S., Qiu, J., Li, Y., Zhou, Y., Shi, J., et al. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00385 · Cited by 27
Abe, S., Takata, H., Shimizu, T., Kawaguchi, Y., Fukuda, S., Yamamoto, H., Ando, H., & Ishida, T. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113821 · Cited by 22
Advances in nanomedicine-based retinal drug delivery: mechanisms and translational applications
Nafar, H., Sharif, P. M., & Rezaei, N. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03848-3 · Cited by 21
Precision Medicines for Retinal Lipid Metabolism-Related Pathologies
da Ana, R., Gliszczyńska, A., Sánchez‐López, E., García, M. L., Krambeck, K., Kovačević, A. B., & Souto, E. B. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040635 · Cited by 24
RNA interference therapeutics for cardiac regeneration
Huntington, J., Pachauri, M., Ali, H., & Giacca, M. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.05.007 · Cited by 18
Truong, L. B., Medina-Cruz, D., & Mostafavi, E. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125185 · Cited by 18
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
Belay, W. Y., Nibret, G., & Aschale, Y. (2023) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s418314 · Cited by 22
Leveraging high-throughput screening technologies in targeted mRNA delivery
Zhang, Y., Gao, Z., Yang, X. Q., Xu, Q., & Lu, Y. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101101 · Cited by 20
Advances in the development of lipid nanoparticles for ophthalmic therapeutics
Chen, S., Deng, Z., & Ji, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117108 · Cited by 17
Ionizable Lipids with Branched Linkers Enhance the Delivery of mRNA Vaccines
Liu, J., Sun, W., Xiao, B., Xu, H., Fan, J., Shi, X., Pan, Y., Qi, W. D., Li, R., Wang, H., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c21289 · Cited by 14
Customizable mRNA Lipid Nanoparticles for Transfection of Primary Human T Cells
VanKeulen‐Miller, R., Huff, J., Narasipura, E. A., Browne, E. P., & Fenton, O. S. (2025) · ACS Nano · doi:10.1021/acsnano.5c15903 · Cited by 18
Wang, S., Guo, B., Wang, H., & Yang, F. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105547 · Cited by 17
Biodegradable Polyester Nanoparticle Vaccines Deliver Self‐Amplifying mRNA in Mice at Low Doses
Wilson, D. R., Tzeng, S. Y., Rui, Y., Neshat, S. Y., Conge, M., Luly, K. M., Wang, E. B., Firestone, J. L., McAuliffe, J., Maruggi, G., et al. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202200219 · Cited by 13
Novel Lipid Nanoparticle (LNP) Delivery Systems Enabling the Advancement of RNA Therapeutics
Zhang, H., Han, S., Zhang, X., Ma, J., Jin, L., Wang, Y., Ma, Y., Ma, T., Yu, F., & Song, G. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505340 · Cited by 18
Shaharyar, M. A., Bhowmik, R., Al-Abbasi, F. A., AlGhamdi, S. A., Alghamdi, A. M., Sarkar, A., Kazmi, I. A., & Karmakar, S. (2023) · Vaccines · doi:10.3390/vaccines11020241 · Cited by 12
Clerck, K. D., Smedt, S. C. D., Remaut, K., & Peynshaert, K. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113849 · Cited by 11
Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases
Geiger, A., Kennedy, J. G., Staker, L. G., Wensel, T. G., Casson, R. J., & Thomas, P. Q. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101376 · Cited by 11
Lau, Y. M. A., Pang, J., Tilstra, G., Couture‐Senécal, J., & Khan, O. F. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2144827 · Cited by 11
Applications and challenges of biomaterial mediated mRNA delivery
Fang, H., & Chen, Q. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00093 · Cited by 13
Lipid/copolymer hybrid drug delivery systems: From design to performance
Triantafyllopoulou, E., Selianitis, D., Chountoulesi, M., Karayianni, M., Valsami, G. N., Pispas, S., & Pippa, Ν. (2026) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2026.103884 · Cited by 12
Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options
Cooper, C. G., Kafetzis, K. N., Patabendige, A., & Tagalakis, A. D. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16229 · Cited by 11
Bailey‐Hytholt, C. M., Ulinski, G., Dugas, J., Haines, M., Lazebnik, M., Piepenhagen, P. A., Zarraga, I. E., & Bandekar, A. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230403094238 · Cited by 12
Protein Release by Controlled Desorption from Transiently Cationic Nanoparticles
Cheung, T. H., Xue, C., Kurtz, D. A., & Shoichet, M. S. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c19877 · Cited by 10
Zimmer, D. N., Schmid, F., & Settanni, G. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c05057 · Cited by 12
Xu, X., An, J., Bai, D., Xu, Y., Wu, T., Yang, H., Yan, Y., Yang, S., Wei, Z., Yao, Y., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114680 · Cited by 9
Pizzi, D., Humphries, J., Morrow, J. P., Mahmoud, A., Fletcher, N. L., Sonderegger, S., Bell, C. A., Thurecht, K. J., & Kempe, K. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c01105 · Cited by 8
Recent Achievements and Perspectives in Smart Nano-in-Micro Platforms for Ocular Disease Treatment
Huang, Y., Yan, D., Ouyang, W., Hu, J., & Liu, Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s518643 · Cited by 7
Peynshaert, K., Devoldere, J., Smedt, S. C. D., & Remaut, K. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2167979 · Cited by 7
Applications and latest research progress of liposomes in the treatment of ocular diseases
Tang, H., Li, X., Jin, L., Dong, J., Li, Y., Li, C., Zhang, L., & Cheng, F. (2025) · Biointerphases · doi:10.1116/6.0004159 · Cited by 9
Kim, S.-G., Park, S. H., Jeong, S., Song, G., Oh, S. S., & Yi, G. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.02.034 · Cited by 7
Knaggs, K. L. M., Sun, Y., Walz, B. A., Pang, J., & Khan, O. F. (2025) · Therapeutic Delivery · doi:10.1080/20415990.2025.2506977 · Cited by 8
Huang, Y., Pang, S., Li, L., Do, C. W., Luo, Q., 郑宗立, & Xiong, W. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114499 · Cited by 12
Han, Y., Wang, Y., Gao, X., Lei, Y., Li, Y., & Tang, Z. (2026) · Cancer Nexus · doi:10.1002/cnx2.70021 · Cited by 10
Simple Scattering: Lipid nanoparticle structural data repository
Kim, L. J., Shin, D. S., Leite, W. C., O’Neill, H., Ruebel, O., Tritt, A., & Hura, G. L. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1321364 · Cited by 5
Gene therapy shines light on congenital stationary night blindness for future cures
Zhang, Y., Lin, S., Yu, L., Lin, X. Y., Qu, S., Ye, Q., Yu, M., Chen, W., & Wu, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06392-8 · Cited by 5
Optimizing the targeting of lipid nanoparticles for gene therapy
Yue, L., Gao, X., Qi, W., Zhang, L., & Wang, Y. (2026) · Nanoscale Horizons · doi:10.1039/d5nh00351b · Cited by 8
Design of messenger RNA vaccines based on lipid-polymer hybrid nanoparticles
Baghel, S. S., Lokras, A. G., Dias, B. A., Landry, M. R., Cérda, S. L., Wadhwa, A., Herrera‐Barrera, M., Thakur, A., Rades, T., Franzyk, H., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114385 · Cited by 7
Self-citationThe stability landscape of mRNA vaccines: challenges and mitigation strategies
Zhong, L., Tao, L., Zhai, Z., Liao, L., Shi, C., Yao, S., & Liu, X. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128515 · Cited by 11
In vivo assessment of triazine lipid nanoparticles as transfection agents for plasmid DNA
Nardo, D., Pitts, M. G., Kaur, R., & Venditto, V. J. (2022) · Biomaterials Science · doi:10.1039/d2bm01289h · Cited by 5
Ji, R., Ishikawa, K., Tan, W., Mori, K., Tsukamoto, R., Matsunaga, N., Kiyohara, K., Fukuda, Y., Wada, I., Isobe, T., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.6.56 · Cited by 5
PEG-free Lipid Nanoparticles for mRNA Delivery: Superhydrophilic Sulfoxide Polymer Coatings
Choy, O. T., Fletcher, N. L., Fu, C., Vu, M. N., Ediriweera, G. R., Humphries, J., Hu, M., Kent, S. J., Cai, R., Chen, C., et al. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c01899 · Cited by 8
Sarode, A., Ortiz, C., Derstepanian, T., Vargas‐Montoya, N., Patel, P., Khadse, N., Manna, S., Landis, R. F., Skaleski, J., Boeglin, L., et al. (2025) · Advanced Materials · doi:10.1002/adma.202517893 · Cited by 18
Wang, T., Li, W., Chen, J., Cheng, S., Gao, M., Jiang, C., Jiang, C., Hu, B., Sung, T., & Higuchi, A. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103044 · Cited by 6
Ongun, M., Lokras, A. G., Foged, C., & Thakur, A. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_11 · Cited by 4
Pastre, A., Brass, O., Terreux, R., & Mégy, S. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c04980 · Cited by 4
Haddadzadegan, S., Mehdizdeh, N., Wang, X., Wong, T. T. L., & Miserez, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114841 · Cited by 5
Mukherjee, S., Shin, S., Devos, C., Udepurkar, A. P., Sagmeister, P., Trout, B. L., Myerson, A. S., & Braatz, R. D. (2026) · ACS Omega · doi:10.1021/acsomega.6c00100 · Cited by 5
Fang, S., Tang, X., Ou, B., Qian, S., Chen, B., Su, J., Feng, J., Yuan, Z., & Zhang, J. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115049 · Cited by 4
Seo, M., Lee, M., Seo, Y.-J., Kim, J., Oh, J., Kim, J., Cho, Y., Chang, J., & Kim, H. (2025) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2025.02.023 · Cited by 4
Paoletti, L., Clerck, K. D., Coster, E. D., Matricardi, P., Remaut, K., & Peynshaert, K. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01921-w · Cited by 4
Nanodelivery systems for gene editing drugs
Zhang, Y., & Ping, Y. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2025-0178 · Cited by 3
Basham, C. M., Haney, M., Zhao, Y., Lukyanov, K. A., Kim, K., Baysal, A., Hutsell, H., Kabanov, A. V., & Ramsey, J. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.05.657891 · Cited by 8
Lee, D., Kwak, G., Johnson, T. V., & Suk, J. S. (2022) · Current Protocols · doi:10.1002/cpz1.607 · Cited by 2
Lipid nanoparticle mediated delivery of dsDNA to the murine retina
Fehrman, R. L., Sahel, D. K., Sahay, G., Lipinski, D. M., & Ryals, R. C. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114194 · Cited by 2
Self-citationSnoeck, J., Cui, X., Vervaeke, P., Sanders, N. N., & Garmyn, A. (2026) · Veterinary Quarterly · doi:10.1080/01652176.2025.2603307 · Cited by 3
mRNA therapy: A novel approach for retinal neurodegenerative diseases
Zhang, B., Tang, J., Zhang, Q., Qiu, Y., Cheng, Y., Yu, S., Liu, L., Xue, J., Liu, X., He, Q., et al. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01306 · Cited by 3
Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases
Bakrania, A. K., Lefebvre, A.-T. N., de Vries, R., Laflamme, M. A., Jaeckel, E., He, H. H., Radvanyi, L. G., Hedtrich, S., Sahay, G., Blakney, A. K., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01476-y · Cited by 3
Self-citationIntrinsically Selective Nanoplatforms for Precision Therapy and Monitoring
Brownsberger, A., Kudary, C., Williams, H. H., Wei, S., Latorre, P., Eastland, R., Sayani, O., Lyu, J., Davey, R., Hopkins, V., et al. (2026) · Journal of Nanotheranostics · doi:10.3390/jnt7020012 · Cited by 2
Appelbaum, T., Smith, D. A., Takahashi, K., Kwok, J., Sorenson, H., & Beltran, W. A. (2025) · Drug Delivery · doi:10.1080/10717544.2025.2544688 · Cited by 2
Sengupta, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91814-5.00007-6 · Cited by 1
Advanced drug delivery systems for enhancing the efficacy of RNA-based therapeutics
Alhabib, N. A., Almaniea, M. A., Alehaidib, S. M., Almansour, M. A., Aldosary, M. S., Almegbel, M. T., Alsubaie, S. A., & Alzahrani, A. M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns10.15029 · Cited by 1
Azevedo, G., Alves, M. T. R., Prazeres, P. H. D. M., da Silva, G. H. C., Fujii, L. H. F., & Guimarães, P. P. G. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126579 · Cited by 3
Tu, J., Ma, R., Jiang, W., Yang, H., Shi, X., Jiang, J., Li, Y., & Liu, X. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02579f · Cited by 1
Goddaer, S., Coster, E. D., Callens, E., Caenegem, E. V., den Heule, O. V., Collin, R. W. J., Peynshaert, K., Nieuwerburgh, F. V., Braeckmans, K., & Remaut, K. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-02036-y · Cited by 2
Srivastava, R. (2026) · Next research. · doi:10.1016/j.nexres.2026.102118 · Cited by 1
Gillman, L., Suleski, D., Graham, M. E., Ginn, S. L., & Hassan, M. M. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00618 · Cited by 2
Recent advances of CRISPR-based gene editing technologies and delivery strategies
Xue, F., Xin, Z., Wang, G., Xing, J., Han, H., Zhao, X., & Song, N. H. (2026) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2026.2702869 · Cited by 1
Advances and Perspectives of Pharmaceutical Nanotechnology in mRNA Therapy
Cheng, H., & Li, Z. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220825145124 · Cited by 1
Wang, Y., Zhang, M., Li, G., Hou, T., Li, Z., Chen, S., Wang, D., & Jiang, W. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-1077 · Cited by 4
Lipid nanoparticles loaded with anticancer bioactives: state of the art
Faria, G. N. F., Bhavsar, D., Munshi, A., & Ramesh, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15401-0.00017-8 · Cited by 2
Research progress on lipid nanoparticle messenger RNA delivery system
He, S., & Liu, S. (2025) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0709 · Cited by 1
Lipid Nanoparticles to Harness the Therapeutic Potential of mRNA for Cancer Treatment
Guevara, M. L., Persano, F., & Persano, S. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_14
mRNA vaccine encoding neoantigen for cancer immunotherapy using mouse melanoma as a model
Sittplangkoon, C., & Palaga, T. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.23 · Cited by 1
mRNA-therapy: problems and prospects of application in nephrology
Айтбаев, К. А., Murkamilov, I. T., Fomin, V. V., Yusupova, T. F., Yusupova, Z. F., Yusupov, F. A., Khakimov, S., Ymankulov, D. S., & Kudaibergenova, I. (2025) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2024-28-4-30-38
Zheng, J. P., Jiang, H., Huang, J., Liu, Q., & Hao, H. (2025) · Journal of Visualized Experiments · doi:10.3791/67711 · Cited by 1
Clerck, K. D., Coster, E. D., Paoletti, L., Smedt, S. C. D., Remaut, K., & Peynshaert, K. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01987-6 · Cited by 6
Lipid nanoparticles enable mRNA delivery to diverse cell types of the inner Retina
Biswas, S., Carpentiero, E., Xhaferri, N., Streckenbach, P., Renigunta, V., & Lindner, M. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102996 · Cited by 1
Linares-Fernández, S. (2021) · theses.fr (ABES) · doi:10.70675/17ec09cezeb11z45f7z8529z7ffbf89d664a · Cited by 1
Drug delivery nanosystems for skeletal muscle treatment in myotonic dystrophy
Repellin, M. (2022) · theses.fr (ABES) · doi:10.70675/905c40e8z03bdz417fz889dzf4930211a75b
Goyal, S., & Vanita, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43986-5.00042-4
Multifunctional nanocomposites for precise control over drug delivery
Andretto, V. (2022) · theses.fr (ABES) · doi:10.70675/7a7f57fez25f2z41a0z9072z3f3cc2aef2d6
Müller cell membrane biomimetic nanocarriers promote cell proliferation via Wnt/JAK-STAT signaling
Chen, S., Qi, X. K., Chen, Y., Li, B., Yang, Q., Li, Z., Deng, Z., Haibo, L., & Ji, D. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114943
Emerging the Potential of mRNA Technology in Covid-19 Vaccine Manufacturing
Taher, M., Rosdi, M. I. A. M., Nur, M. S. I. M. N., Zainuri, Q. A., Shokri, N. S. I. M. N., Pazli, N. H. M., Susanti, D., Zaini, E., & Khotib, J. (2026) · Springer handbooks · doi:10.1007/978-3-032-01636-2_16
Camoglu, H., Yoldas, B., & Kaçar, G. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108529
Ou, B., Tang, X., Qian, S., Chen, B., Fang, S., Su, J., Sheng, X., Feng, J., Yuan, Z., & Zhang, J. (2026) · Small · doi:10.1002/smll.74730
Yu, M., Wang, L., Elliott, T., Wang, X., Mathew, A., Qiu, B., Yao, L., Wang, W., & Zhang, N. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.180282 · Cited by 1
mRNA lipid nanoparticle vaccines: current status, challenges and future prospects
吴志能, Lou, J., Cheng, Y., Li, M., Wang, Z., Liu, N., Gao, X., Zheng, A., & Zhang, H. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00600-7
Brovin, A. N., Sabantsev, M. O., Ignatieva, E. V., Baibarin, K. А., & Karabelsky, A. V. (2026) · Ophthalmology in Russia · doi:10.18008/1816-5095-2026-3-512-520
Wang, W., Song, J., Du, Y., Zhou, C., Zuo, X., You, G., Luo, C., Huang, Y., Jiang, Z., Li, X., et al. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.109083
Metadata
- Authors
- Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G.
- Affiliations
- Oregon Health & Science University (US)
- Oregon State University (US)
- Corresponding author
- Sahay, Gaurav
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-10-29
- Volume
- 15
- Issue
- 10
- Pages
- e0241006
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7595320
- OpenAlex
- W3096490487
- Cited by
- 194
- References
- 40
- Citations by year
- 2026: 30 · 2025: 42 · 2024: 32 · 2023: 37 · 2022: 35 · 2021: 17 · 2020: 1
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P30 EY010572)
- National Eye Institute (1R21EY031066-01A1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- PEGylation, lipid nanoparticles, mRNA delivery, ocular gene therapy, retinal degeneration, subretinal injection, intravitreal injection, retinal pigment epithelium, apolipoprotein E, MERTK, Müller cells, optic nerve head, trabecular meshwork, particle size
- MeSH terms
- Mice, Knockout, ApoE, Red Fluorescent Protein, Animals, Female, Fundus Oculi, Lipids, Luminescent Proteins, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Particle Size, Polyethylene Glycols, RNA, Messenger, Drug Delivery Systems, Gene Transfer Techniques, Nanoparticles, Retinal Pigment Epithelium, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.